Eitr Biologics
Business Services · 11-50 Employees
View Company Info for Free
Overview
Website
www.eitrbio.comRevenue
<$5 MillionIndustry
About Eitr Biologics
Eitr Biologics Org Chart
Is Eitr Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Eitr Biologics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Eitr Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Eitr Biologics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Eitr Biologics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Eitr Biologics launches new products
Click to see if Eitr Biologics had a recent Job posting/layoffs
Check out if Eitr Biologics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Eitr Biologics
Recommended Actions
Reach out to Masked Content who joined Eitr Biologics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Eitr Biologics
Compare insights from companies similar to Eitr Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Eitr Biologics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Eitr Biologics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Eitr Biologics.
Eitr Biologics Tech Stack
A closer look at the technologies used by Eitr Biologics
Top Business Services Companies
Frequently Asked Questions Regarding Eitr Biologics
Eitr Biologics specializes in the development of innovative immunotherapeutics through its Orthogonal Dual-Interacting Nanotherapeutic (ODIN) platform, which focuses on single domain antibody-based technologies. The company aims to create highly potent treatments for oncology, antibacterials, and antivirals, leveraging the unique capabilities of it... Read More
